INFUSYSTEM HOLDINGS, INC Proceeds from Long-term Lines of Credit
INFUSYSTEM HOLDINGS, INC (INFU) reported Proceeds from Long-term Lines of Credit of $2.50 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2012-05-21
- INFUSYSTEM HOLDINGS, INC proceeds from long-term lines of credit for the quarter ending 2012-03-31 was $2.50M.
- INFUSYSTEM HOLDINGS, INC proceeds from long-term lines of credit for fiscal 2011 was $1.75M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|
| 2012-03-31 | $2.50M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $1.75M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |